Evaluation of PKU Sphere Liquid

Status Completed

Clinical Trial Summary

PKU Sphere Liquid is a prospective, open-label, acceptability study to evaluate PKU sphere liquid in up to 15 participants aged 3 and above for the dietary management of PKU over 31 days.

Clinical Trial Description

PKU Sphere Liquid is a newly-developed Food for Special Medical Purposes (FSMP) designed for the dietary management of patients with phenylketonuria (PKU). PKU sphere liquid is a vanilla flavoured, ready-to-drink, low phenylalanine protein substitute containing a blend of casein glycomacropeptide (GMP) isolate, essential and non-essential amino acids, carbohydrate, fat, vitamins, minerals, and Docosachexaenoic acid (DHA). This is a feasibility study designed to evaluate the acceptability, tolerance and adherence of children and adults consuming PKU sphere liquid. Participants will be given a four-week supply of PKU Sphere Liquid and they will be asked to complete a daily diary and short questionnaire for four weeks to record information on: adherence, gastrointestinal tolerance, palatability and how the product is used. Each participant will be on the trial for 31 days. This includes a 3-day baseline period and 28 days taking the study product. If deemed appropriate in each individual circumstance, the sponsor of the trial, Vitaflo International Ltd, will continue to supply the product free of charge at the end of the trial until available on prescription. ;

Study Design

Related Conditions & MeSH terms

Phenylketonurias

Clinical Trial Details

NCT number	NCT05096988
Study type	Interventional
Source	Vitaflo International, Ltd
Contact
Status	Completed
Phase	N/A
Start date	November 23, 2021
Completion date	February 28, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05998109` - PheCheck Feasibility Study
Not yet recruiting	`NCT04433728` - Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002.
Completed	`NCT01209819` - Bone Mineral Density in Adults With Hyperphenylalaninemia	N/A
Active, not recruiting	`NCT05174559` - Additional Dietary Large Neutral Amino Acids (LNAA) for Improved Symptoms in Adult Classical Phenylktonuria (PKU)	N/A
Not yet recruiting	`NCT04969809` - Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients	N/A
Recruiting	`NCT04404530` - Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
Recruiting	`NCT05827536` - Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.	N/A
Active, not recruiting	`NCT05971563` - Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers	N/A
Enrolling by invitation	`NCT03655223` - Early Check: Expanded Screening in Newborns
Completed	`NCT04368624` - PKU Skin Stripping
Completed	`NCT04452513` - A Prospective Clinical Study of Phenylketonuria (PKU)
Completed	`NCT05497050` - The Effect of Nursing Empowerment Program	N/A
Completed	`NCT04943393` - Remote Neurocognitive and Psychological Assessment in PKU
Completed	`NCT00225615` - A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels	Phase 3
Recruiting	`NCT05128149` - Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?
Terminated	`NCT05229549` - Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria	N/A
Enrolling by invitation	`NCT05356377` - Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
Not yet recruiting	`NCT06332807` - AAV Gene Therapy Clinical Study in Adult Classic PKU	Phase 1/Phase 2
Not yet recruiting	`NCT06337864` - Evaluating the Efficacy and Safety of Large Neutral Amino Acids in the Treatment of Classical Phenylketonuria	N/A
Completed	`NCT02445521` - Testing of Four Home Phenylalanine Monitoring Prototype Devices	N/A